Navigation Links
UQ scientists break new ground in fight against infection & chronic disease

University of Queensland (UQ) researchers are on track to develop new treatments for acute infections, chronic inflammatory diseases and cancer.

The research could revolutionise treatments for conditions such as bird flu, arthritis, and inflammatory bowel disease, by using a mechanism that gives the human body a more rapid response to infections.

The discovery, made by four researchers from UQ's Institute for Molecular Bioscience (IMB), will be published in the December 2nd edition of the world's leading scientific journal Science.

It involves cells in the front line of defence against infection, called macrophages, releasing messengers to fight and kill disease-causing microbes.

IMB researchers Professor Jennifer Stow, Dr Rachael Murray, Mr Jason Kay and Mr Daniele Sangermani discovered macrophages use a single pathway to orchestrate two different responses to disease.

Professor Stow said when disease-causing microbes infect the body, macrophages respond by engulfing and killing the microbes.

"The cells also release chemical messengers to boost immunity," Professor Stow said.

She said the research was made possible by advanced technologies at the IMB such as live cell microscopy and gene analysis, which are unique in Queensland.

"By using these technologies we were able to show, for the first time, both actions occur simultaneously and a common cellular pathway is used for releasing messengers and for eating microbes," she said.

"This adaptation ensures the whole immune system responds to an infection in the most efficient and rapid way possible.

"In some situations, this clever time-saving device could be a life-saver."

Professor Stow said the study also looked at why having a "hair-trigger" immune response is a dangerous thing.

She said these chemical messengers were among the agents that caused patients to die from acute infections like bird flu and to acqu ire chronic inflammatory diseases such as arthritis and inflammatory bowel disease. They are also behind the muscle wasting experienced by patients with cancer.

Chronic inflammatory disorders are a substantial burden in social and economic terms for the Australian community.

Arthritis alone afflicts 3.4 million Australians and the financial costs were more than $19.25 billion in 2004.

"This discovery provides new and exciting avenues for drug development," Professor Stow said.

"Knowledge of the pathway will help find strategies to combat both acute infection and chronic inflammation and to explore new avenues for treatment of cancer.

"Basic research findings such as this underpin all medical research but there is still a long way to go (upwards of 10 years) until any new drugs begin to emerge on the market."


'"/>

Source:Research Australia


Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
Breaking Biology News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... NBIX ) today announced its financial results for the quarter ... --> For the fourth quarter of 2015, the ... per share, compared to a net loss of $19.4 million, or ... the year ended December 31, 2015, the Company reported a net ... to a net loss of $60.5 million, or $0.81 loss per ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit organization ... researched, developed, marketed and made accessible to patients around the ... had named the publication of the Good Pharma ... publication is also featured as one of BMJ Open ... last year that are most frequently read. Ed ...
(Date:2/11/2016)... (PRWEB) , ... February 11, ... ... business-to-business publication dedicated to delivering cutting-edge information focused on the development and ... Sciences to become a premier sponsor of the 2016 BioProcess International Awards ...
Breaking Biology Technology: